Clinical Trials Logo

Filter by:
NCT ID: NCT00190541 Completed - Rectal Neoplasms Clinical Trials

Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the of international standard operation, mesorectal excision (ME alone) compared to Japanese standard operation, ME with lateral lymph node dissection for clinical stage II, III lower rectal cancer

NCT ID: NCT00190528 Terminated - Cervical Neoplasms Clinical Trials

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer

Start date: February 2002
Phase: Phase 3
Study type: Interventional

To investigate the clinical benefits of neoadjuvant chemotherapy for bulky stage I/II cervical cancer

NCT ID: NCT00190515 Completed - Clinical trials for Colorectal Neoplasms

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

Start date: February 2003
Phase: Phase 3
Study type: Interventional

To evaluate the clinical effectiveness of oral UFT/LV comparing 5-FU/l-LV as adjuvant therapy for stage III colorectal cancer.

NCT ID: NCT00190489 Completed - Breast Cancer Clinical Trials

A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

Start date: January 1999
Phase: Phase 3
Study type: Interventional

To investigate the clinical benefits of Docetaxel or alternating AC-Docetaxel in comparison with standard AC for metastatic breast cancer

NCT ID: NCT00190476 Terminated - Clinical trials for Non-small-cell Lung Cancer

Elderly NSCLC/D vs DP (JCOG0207)

Start date: April 2003
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of docetaxel-cisplatin combination in comparison to docetaxel alone for elderly patients with advanced non-small-cell lung cancer.

NCT ID: NCT00189774 Completed - Clinical trials for Type 2 Diabetes Mellitus

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment.

NCT ID: NCT00189761 Completed - Clinical trials for Graft Versus Host Disease

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Start date: n/a
Phase: Phase 2
Study type: Interventional

A study to assess efficacy, safety and pharmacokinetics of a tacrolimus new oral formulation (MR4) in de novo bone marrow transplant recipients

NCT ID: NCT00189748 Completed - Clinical trials for Graft Versus Host Disease

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Start date: August 2004
Phase: Phase 2
Study type: Interventional

To assess safety and efficacy of the patients with MR4 therapy in GVHD prophylaxis study who are eligible for the administration after 100 days post transplant (up to 1 year)

NCT ID: NCT00189696 Completed - Clinical trials for Irritable Bowel Syndrome

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Start date: n/a
Phase: Phase 3
Study type: Interventional

This study will examine the efficacy, safety and tolerability of oral dose of YM060, 5-HT3 receptor antagonist, in patients with d-IBS.

NCT ID: NCT00184743 Completed - Clinical trials for Adult Growth Hormone Deficiency

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Start date: December 6, 2003
Phase: Phase 3
Study type: Interventional

This trial is conducted in Japan. To investigate the long-term efficacy as assessed by change in fat mass and safety after 48 weeks of treatment of Growth Hormone in adults with Growth Hormone Deficiency, comparing two different treatment regiments.